Bridgefront Capital, LLC Takeda Pharmaceutical CO LTD Transaction History
Bridgefront Capital, LLC
- $236 Million
- Q2 2024
A detailed history of Bridgefront Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bridgefront Capital, LLC holds 21,373 shares of TAK stock, worth $296,016. This represents 0.12% of its overall portfolio holdings.
Number of Shares
21,373
Previous 20,278
5.4%
Holding current value
$296,016
Previous $281,000
1.78%
% of portfolio
0.12%
Previous 0.22%
Shares
8 transactions
Others Institutions Holding TAK
# of Institutions
320Shares Held
70.4MCall Options Held
939KPut Options Held
233K-
Capital Research Global Investors Los Angeles, CA13.1MShares$182 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X07.74MShares$107 Million1.74% of portfolio
-
Morgan Stanley New York, NY4.99MShares$69.1 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$60.2 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY3.72MShares$51.5 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...